Imeik Technology Development Co (300896) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Imeik Technology Development Co (300896) has a cash flow conversion efficiency ratio of 0.032x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥257.61 Million ≈ $37.70 Million USD) by net assets (CN¥8.16 Billion ≈ $1.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Imeik Technology Development Co - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Imeik Technology Development Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Imeik Technology Development Co (300896) total liabilities for a breakdown of total debt and financial obligations.
Imeik Technology Development Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Imeik Technology Development Co ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Protagonist Therapeutics Inc
NASDAQ:PTGX
|
-0.003x |
|
OHB SE
XETRA:OHB
|
-0.052x |
|
ShenZhen YUTO Packaging Technology Co Ltd
SHE:002831
|
0.052x |
|
Lagercrantz Group AB (publ)
ST:LAGR-B
|
0.132x |
|
Big Shopping Centers Ltd
TA:BIG
|
0.014x |
|
COSCO SHIPPING Holdings Co. Ltd
F:C6G
|
0.025x |
|
Macy’s Inc
NYSE:M
|
0.243x |
|
SIGMASTAR TECH LTD
SHE:301536
|
0.014x |
Annual Cash Flow Conversion Efficiency for Imeik Technology Development Co (2014–2025)
The table below shows the annual cash flow conversion efficiency of Imeik Technology Development Co from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Imeik Technology Development Co worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥8.16 Billion ≈ $1.19 Billion |
CN¥1.39 Billion ≈ $202.93 Million |
0.170x | -29.93% |
| 2024-12-31 | CN¥7.95 Billion ≈ $1.16 Billion |
CN¥1.93 Billion ≈ $282.01 Million |
0.242x | -19.55% |
| 2023-12-31 | CN¥6.49 Billion ≈ $948.97 Million |
CN¥1.95 Billion ≈ $285.94 Million |
0.301x | +50.06% |
| 2022-12-31 | CN¥5.95 Billion ≈ $870.05 Million |
CN¥1.19 Billion ≈ $174.71 Million |
0.201x | +7.13% |
| 2021-12-31 | CN¥5.03 Billion ≈ $736.01 Million |
CN¥942.78 Million ≈ $137.96 Million |
0.187x | +99.53% |
| 2020-12-31 | CN¥4.53 Billion ≈ $663.06 Million |
CN¥425.68 Million ≈ $62.29 Million |
0.094x | -79.90% |
| 2019-12-31 | CN¥662.70 Million ≈ $96.97 Million |
CN¥309.72 Million ≈ $45.32 Million |
0.467x | +39.60% |
| 2018-12-31 | CN¥404.74 Million ≈ $59.23 Million |
CN¥135.50 Million ≈ $19.83 Million |
0.335x | +30.60% |
| 2017-12-31 | CN¥328.31 Million ≈ $48.04 Million |
CN¥84.16 Million ≈ $12.32 Million |
0.256x | +23.74% |
| 2016-12-31 | CN¥265.49 Million ≈ $38.85 Million |
CN¥55.00 Million ≈ $8.05 Million |
0.207x | -35.02% |
| 2015-12-31 | CN¥151.66 Million ≈ $22.19 Million |
CN¥48.35 Million ≈ $7.07 Million |
0.319x | +0.43% |
| 2014-12-31 | CN¥88.06 Million ≈ $12.89 Million |
CN¥27.95 Million ≈ $4.09 Million |
0.317x | -- |
About Imeik Technology Development Co
Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate compos… Read more